Exploring the motivations for microdosing offers profound insights into creativity, depression, and anxiety. With contrasting data showcasing 4,600 non-microdosers versus 4,000 microdosers, the discussion sheds light on the growing community of citizen scientists interested in the potential benefits of psychedelics. Paul Stamets, a renowned mycologist and advocate for the medicinal use of fungi, delves into how microdosing could address mental health challenges like anxiety and depression. Discover what might be holding you back from accessing your true creative potential and the fascinating aspects of this emerging topic.